In Florida, Akron Biotechnology, LLC joined the New Hampshire based Manufacturing USA initiative, called the Advanced Regenerative Manufacturing Institute, to help develop and manufacture tissue and organs. The ARMI initiative is comprised of almost 100 organizations and includes $80 million in funding from the federal government and over $200 million from industry organizations, academic institutions, and non-profits. The program’s network invests in leading manufacturing and biofabrication technologies as well as biomaterial and cell processing for the Department of Defense. Their goal is to grow American manufacturing and incentivize companies to invest within the United States to move forward and improve biofabrication technology especially for cells, organs and tissue.
Home Biomaterials No Need to Wait for Organ Transplant? Organ and Tissue Manufacturing Initiative...
Latest article
Fin-ished, for now: Aqua Cultured Foods shutters as funding dries up
In Chicago, a fermentation startup converting cellulose into seafood alternatives has wound down operations after failing to raise funds necessary to reach commercialization.
Established...
Mercedes unveils vegan-interior SUV at CES
In Nevada, Mercedes-Benz has showcased a new, vegan-interior GLC electronic SUV at the recent CES technology trade show in Las Vegas.
Vegan materials were...
Futerro files permits for French PLA site
In France, biobased chemicals maker Futerro has requested the relevant permits for its planned lactic acid and polylactic acid plant in France.
The plant, which...